Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Abstract 1086: Discoidin domain receptor 1 contributes to tumorigenesis through modulation of TGFBI expression

Nandini Rudra-Ganguly, Daulet Satpayev, Christine Lowe, Liping Hu, Bally Randhawa, Mi Sook Chang, Alla Verlinsky, Jeffrey Coleman, Pia Challita-Eid, Peng Yang, Zili An, Karen Morrison, Art Raitano, Daniel S. Pereira, David Stover

Cancer Res (2012) 72 (8_Supplement): 1086.

https://doi.org/10.1158/1538-7445.AM2012-1086

Published: 15 April 2012

View articletitled, Abstract 1086: Discoidin domain receptor 1 contributes to tumorigenesis through modulation of TGFBI expression

Journal Articles

Abstract #2643: YAP1 induces the transformation of human MCF10A mammalian epithelial cells by regulating microRNAs expression

Liping Hu, Yiwei Tony Zhu, Chao Qi, Yijun Zhu

Cancer Res (2009) 69 (9_Supplement): 2643.

Published: 01 May 2009

View articletitled, Abstract #2643: YAP1 induces the transformation of human MCF10A mammalian epithelial cells by regulating microRNAs expression

Journal Articles

Identification of Smyd4 as a Potential Tumor Suppressor Gene Involved in Breast Cancer Development

Liping Hu, Yiwei Tony Zhu, Chao Qi, Yi-Jun Zhu

Cancer Res (2009) 69 (9): 4067–4072.

https://doi.org/10.1158/0008-5472.CAN-08-4097

Published: 30 April 2009

View articletitled, Identification of Smyd4 as a Potential Tumor Suppressor Gene Involved in Breast Cancer Development

Includes: Supplementary data

Journal Articles

Identification of Smyd4 by chromosome rearrangement as a potential tumor suppressor gene involved in breast cancer development

Liping Hu, Yiwei Zhu, Chao Qi, Yijun Zhu

Cancer Res (2008) 68 (9_Supplement): 184.

Published: 01 May 2008

View articletitled, Identification of Smyd4 by chromosome rearrangement as a potential tumor suppressor gene involved in breast cancer development

Journal Articles

The Proteasome Inhibitor PS-341 (Bortezomib) Up-Regulates DR5 Expression Leading to Induction of Apoptosis and Enhancement of TRAIL-Induced Apoptosis Despite Up-Regulation of c-FLIP and Survivin Expression in Human NSCLC Cells

Xiangguo Liu, Ping Yue, Shuzhen Chen, Liping Hu, Sagar Lonial, Fadlo R. Khuri, Shi-Yong Sun

Cancer Res (2007) 67 (10): 4981–4988.

https://doi.org/10.1158/0008-5472.CAN-06-4274

Published: 17 May 2007

View articletitled, The Proteasome Inhibitor PS-341 (Bortezomib) Up-Regulates DR5 Expression Leading to Induction of Apoptosis and Enhancement of TRAIL-Induced Apoptosis Despite Up-Regulation of c-FLIP and Survivin Expression in Human NSCLC Cells

Includes: Supplementary data

Journal Articles

The proteasome inhibitor PS-341 (Bortezomib) upregulates death receptor 5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite increase of c-FLIP and survivin in human lung cancer cells.

Xiangguo Liu, Ping Yue, Shuzhen Chen, Liping Hu, Sagar Lonial, Fadlo Khuri, Shi-yong Sun

Cancer Res (2007) 67 (9_Supplement): 2406.

Published: 01 May 2007

View articletitled, The proteasome inhibitor PS-341 (Bortezomib) upregulates death receptor 5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite increase of c-FLIP and survivin in human lung cancer cells.

Journal Articles

Enhanced Sensitivity of Multiple Myeloma Cells Containing PTEN Mutations to CCI-779

Yijiang Shi, Joseph Gera, Liping Hu, Jung-hsin Hsu, Robert Bookstein, Weiqun Li, Alan Lichtenstein

Cancer Res (2002) 62 (17): 5027–5034.

Published: 01 September 2002

View articletitled, Enhanced Sensitivity of Multiple Myeloma Cells Containing PTEN Mutations to CCI-779

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 1086: Discoidin domain receptor 1 contributes to tumorigenesis through modulation of TGFBI expression

Abstract #2643: YAP1 induces the transformation of human MCF10A mammalian epithelial cells by regulating microRNAs expression

Identification of Smyd4 as a Potential Tumor Suppressor Gene Involved in Breast Cancer Development

Identification of Smyd4 by chromosome rearrangement as a potential tumor suppressor gene involved in breast cancer development

The Proteasome Inhibitor PS-341 (Bortezomib) Up-Regulates DR5 Expression Leading to Induction of Apoptosis and Enhancement of TRAIL-Induced Apoptosis Despite Up-Regulation of c-FLIP and Survivin Expression in Human NSCLC Cells

The proteasome inhibitor PS-341 (Bortezomib) upregulates death receptor 5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite increase of c-FLIP and survivin in human lung cancer cells.

Enhanced Sensitivity of Multiple Myeloma Cells Containing PTEN Mutations to CCI-779

Email alerts

AACR Journals

Update search

Abstract 1086: Discoidin domain receptor 1 contributes to tumorigenesis through modulation of TGFBI expression

Abstract #2643: YAP1 induces the transformation of human MCF10A mammalian epithelial cells by regulating microRNAs expression

Identification of Smyd4 as a Potential Tumor Suppressor Gene Involved in Breast Cancer Development

Identification of Smyd4 by chromosome rearrangement as a potential tumor suppressor gene involved in breast cancer development

The Proteasome Inhibitor PS-341 (Bortezomib) Up-Regulates DR5 Expression Leading to Induction of Apoptosis and Enhancement of TRAIL-Induced Apoptosis Despite Up-Regulation of c-FLIP and Survivin Expression in Human NSCLC Cells

The proteasome inhibitor PS-341 (Bortezomib) upregulates death receptor 5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite increase of c-FLIP and survivin in human lung cancer cells.

Enhanced Sensitivity of Multiple Myeloma Cells Containing PTEN Mutations to CCI-779

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only